Disseminated coccidioidomycosis
| Disseminated coccidioidomycosis | |
|---|---|
| Other names | Coccidioidal granuloma |
 | |
| Characteristic skin granulomata on the forehead. | |
| Specialty | Infectious diseases |
Disseminated coccidioidomycosis is a systemic infection with Coccidioides immitis, in which 15-20% of people develop skin lesions.[1]: 315
History of Treatment
[edit] | This section may require copy editing. (December 2024) |
In 1959 "Disseminated Coccidioidomycosis Treated with Amphotericin B" was published in the New York State Journal of Medicine, documenting perhaps one of the earliest uses of the drug, amphotericin B, for a patient who was admitted to the U.S. Public Health Service Hospital in Seattle, Washington. "Disseminated coccidioidomycosis had been lacking specific chemotherapeutic treatment until approximately three years ago when a polyene, antifungal antibiotic, amphotericin B, was tired. Since then there have been a number of reports on the beneficial clinical effect of the drug in patients with coccidioidomycosis. The reader is referred to Littman, Horowitz, and Swadey's article for a review of the salient features of coccidioidomycosis as well as the characteristics of amphotericin B. The purpose of this paper is to present another case of disseminated coccidioidomycosis treated with amphotericin B and followed for fourteen months.[2]
See also
[edit]References
[edit]- ^ James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: Clinical Dermatology. Saunders Elsevier. ISBN 0-7216-2921-0.
- ^ La Barbera, M.D., Salvatore A. (October 1, 1959). "Disseminated Coccidioidomycosis Treated with Amphotericin B". New York State Journal of Medicine. 59 (19): 3644.